In case your Tax-Free Financial savings Account (TFSA) is sitting in money or a low-yield assured earnings certificates, you might be leaving an unlimited sum of money on the desk. And I imply that actually.
The TFSA is likely one of the strongest wealth-building instruments ever handed to a Canadian investor, however it solely works if you happen to deal with it like an funding account and never a digital piggy financial institution.
Proper now, one TSX inventory that deserves critical consideration to your TFSA is Tecsys (TSX:TCS), a Canadian software program firm that simply delivered its finest quarterly earnings in historical past.
Supply: Getty Pictures
The TFSA is an funding account
The federal authorities launched the TFSA in 2009 and, with respect, picked a horrible title. That one phrase, “Financial savings,” has satisfied thousands and thousands of Canadians to park their contribution room in money, incomes 2–3% yearly.
Right here is the issue with that. As of 2026, the lifetime cumulative TFSA contribution room sits at $109,000 for these eligible since inception. At 4% yearly, that $109,000 grows to roughly $218,000 over 18 years.
Comparatively, the S&P 500 Index has returned 10% yearly on common over the previous six many years. So, investing in low-cost index funds that observe the S&P 500 will help you double your cash in simply over seven years.
A $109,000 funding can develop to greater than $600,000 over 18 years at a ten% compounded annual progress charge.
Tecsys is a high TFSA inventory to personal
In its fiscal third quarter of 2026, Tecsys delivered adjusted earnings earlier than curiosity, taxes, depreciation, and amortization (EBITDA) of $5 million, up 43% from the identical interval a yr earlier.
In line with Tecsys CEO Peter Brereton, it was the best quarter of adjusted EBITDA within the firm’s historical past.
- SaaS income grew 17% yr over yr to $20.1 million.
- SaaS annual recurring income (ARR) reached $83.3 million, up 16% on a continuing foreign money foundation.
- Most significantly, the corporate’s Elite SaaS ARR, its core product line and the first progress engine, grew 23% on a continuing foreign money foundation, accelerating from 21% within the prior quarter.
Tecsys serves two high-demand verticals: healthcare provide chains and distribution. In Q3, it signed new logos, together with the Memorial Sloan Kettering Most cancers Middle and UT Southwestern, two of probably the most revered educational medical facilities in the US.
The pipeline coming into This fall was up 30% in comparison with the identical interval final yr. New emblem bookings over the trailing 12 months had been up greater than 150%. And this was achieved with none migration bookings, which means the demand was fully natural.
The corporate additionally commercially launched TecsysIQ, its synthetic intelligence layer that integrates information from inner techniques and exterior healthcare-specific sources, such because the U.S. Meals and Drug Administration and the International Distinctive System Identification Database.
Brereton described it plainly on the earnings name: synthetic intelligence with out underlying information simply hallucinates. Tecsys supplies the info basis that makes its AI capabilities meaningfully completely different from the generic AI instruments flooding the market.
The Silly takeaway
Analysts monitoring the TSX tech inventory forecast its free money circulation to broaden from $11.2 million in 2025 to $45 million in 2030. If the small-cap inventory is priced at 20 instances ahead FCF, it might nearly double throughout the subsequent 4 years.
Development shares like Tecsys are exactly the sort of holding that turns the TFSA into the wealth accelerator it was designed to be. When a inventory doubles or triples over a decade, the capital achieve inside a TFSA is fully yours to maintain.
Tecsys is a worthwhile, rising software program enterprise with a sticky buyer base, low churn (underneath 2% in its Elite tier), and an increasing moat in healthcare logistics, one of the vital recession-resistant markets on earth. The corporate reaffirmed full-year fiscal 2026 steering for SaaS income progress of 20–22% and adjusted EBITDA margins of 8–9%.
Given consensus value targets, the TSX tech inventory provides a 21% upside from present ranges.
